Aspira Pathlab files FY26 annual report, 53rd AGM notice

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Aspira Pathlab filed its FY26 annual report with BSE on August 31, 2026
  • The filing includes audited financial statements and the 53rd AGM notice
  • Compliance is under SEBI LODR Regulation 34
  • Documents are accessible via email to registered members and the company website
powered bylight_fuzz_icon
49732626

*this image is generated using AI for illustrative purposes only.

Aspira Pathlab & Diagnostics Limited filed its annual report for the financial year ended March 31, 2026, with the Bombay Stock Exchange on August 31, 2026. The submission includes the notice for the company's 53rd Annual General Meeting.

The Aspira Pathlab filing complies with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document contains standalone audited financial statements, the Board's Report, and the Auditors' Report.

Filing Details

The annual report and AGM notice are being emailed to members who have registered their email addresses with the company, its Registrar and Transfer Agent, MUFG Intime India Private Limited, or Depository Participants.

Document Status
Annual Report FY26 Submitted
53rd AGM Notice Enclosed
Submission Date August 31, 2026
Exchange BSE Limited

The documents are also available on the company's official website. Neetu Maurya, Company Secretary and Compliance Officer, signed the submission letter addressed to the Listing Department of BSE Limited.

Historical Stock Returns for Aspira Pathlab

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+1.05%-18.31%+59.65%+44.44%0.0%

How will the audited financial results for FY26 influence Aspira Pathlab's valuation and stock performance in the coming quarter?

What specific growth initiatives or expansion plans are likely to be discussed during the upcoming 53rd Annual General Meeting?

Are there any significant changes in the Board of Directors or management structure revealed in the report that could impact future corporate strategy?

Aspira Pathlab sets Sep 25 record date for 53rd annual general meeting

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Aspira Pathlab sets book closure from September 19 to 25, 2026
  • The 53rd AGM is scheduled for September 25, 2026, at 2:00 pm
  • E-voting will be open from September 22 to September 24, 2026
  • Cut-off date for shareholding eligibility is September 18, 2026
powered bylight_fuzz_icon
49729725

*this image is generated using AI for illustrative purposes only.

Aspira Pathlab & Diagnostics Limited has set September 19 to September 25, 2026 as the book closure period for its 53rd Annual General Meeting. The meeting is scheduled for September 25, 2026, and will be conducted via video conferencing or other audio-visual means.

The company notified the BSE Limited regarding these dates on August 31, 2026. Shareholders holding equity shares as of the cut-off date of September 18, 2026, will be eligible to vote.

Key Dates for AGM

Event Date/Time
Cut-off date September 18, 2026
Book closure start September 19, 2026
Book closure end September 25, 2026
E-voting start September 22, 2026 at 9:00 am
E-voting end September 24, 2026 at 5:00 pm
AGM date September 25, 2026 at 2:00 pm

Voting Process

The e-voting facility will be available from 9:00 am on September 22, 2026, until 5:00 pm on September 24, 2026. The general meeting adheres to guidelines issued by the Ministry of Corporate Affairs and SEBI circulars regarding remote participation.

Neetu Maurya, Company Secretary & Compliance Officer, issued the intimation. The company’s registered office is located in Mumbai.

Historical Stock Returns for Aspira Pathlab

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+1.05%-18.31%+59.65%+44.44%0.0%

What key financial resolutions or strategic initiatives are expected to be tabled at Aspira Pathlab's 53rd AGM?

How might the company's recent performance in the diagnostics sector influence shareholder voting patterns during the upcoming AGM?

Are there any anticipated changes to the board of directors or executive compensation structures to be discussed at the meeting?

More News on Aspira Pathlab

1 Year Returns:+44.44%